Telegraph.co.uk | What is Nice? Drugs body Q&A Telegraph.co.uk Last March it rejected Afinitor (everolimus), which costs about £36,000 a time on grounds of cost, saying there was no evidence it was better than treatments already available. :: At the same time the body turned down Inlyta (axitinib) for kidney ... |
